Literature DB >> 18092949

Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.

Peter P Jones1, Dawei Jiang, Jeff Bolstad, Donald J Hunt, Lin Zhang, Nicolas Demaurex, S R Wayne Chen.   

Abstract

A number of RyR2 (cardiac ryanodine receptor) mutations linked to ventricular arrhythmia and sudden death are located within the last C-terminal approximately 500 amino acid residues, which is believed to constitute the ion-conducting pore and gating domain of the channel. We have previously shown that mutations located near the C-terminal end of the predicted TM (transmembrane) segment 10, the inner pore helix, can either increase or decrease the propensity for SOICR (store-overload-induced Ca2+ release), also known as spontaneous Ca2+ release. In the present study, we have characterized an RyR2 mutation, V4653F, located in the loop between the predicted TM 6 and TM 7a, using an ER (endoplasmic reticulum)-targeted Ca2+-indicator protein (D1ER). We directly demonstrated that SOICR occurs at a reduced luminal Ca2+ threshold in HEK-293 cells (human embryonic kidney cells) expressing the V4653F mutant as compared with cells expressing the RyR2 wild-type. Single-channel analyses revealed that the V4653F mutation increased the sensitivity of RyR2 to activation by luminal Ca2+. In contrast with previous reports, the V4653 mutation did not alter FKBP12.6 (FK506-binding protein 12.6 kDa; F506 is an immunosuppressant macrolide)-RyR2 interaction. Luminal Ca2+ measurements also showed that the mutations R176Q/T2504M, S2246L and Q4201R, located in different regions of the channel, reduced the threshold for SOICR, whereas the A4860G mutation, located within the inner pore helix, increased the SOICR threshold. We conclude that the cytosolic loop between TM 6 and TM 7a plays an important role in determining the SOICR threshold and that the alteration of the threshold for SOICR is a common mechanism for RyR2-associated ventricular arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18092949     DOI: 10.1042/BJ20071287

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

Review 1.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

2.  Role of presenilins in neuronal calcium homeostasis.

Authors:  Hua Zhang; Suya Sun; An Herreman; Bart De Strooper; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

Review 3.  FK506-binding proteins 12 and 12.6 (FKBPs) as regulators of cardiac Ryanodine Receptors: Insights from new functional and structural knowledge.

Authors:  Luis A Gonano; Peter P Jones
Journal:  Channels (Austin)       Date:  2017-06-21       Impact factor: 2.581

4.  Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Dawei Jiang; Peter P Jones; Darryl R Davis; Robert Gow; Martin S Green; David H Birnie; S R Wayne Chen; Michael H Gollob
Journal:  Channels (Austin)       Date:  2010-07-14       Impact factor: 2.581

5.  Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias.

Authors:  Zhichao Xiao; Wenting Guo; Bo Sun; Donald J Hunt; Jinhong Wei; Yingjie Liu; Yundi Wang; Ruiwu Wang; Peter P Jones; Thomas G Back; S R Wayne Chen
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

Review 6.  Functional interaction between calsequestrin and ryanodine receptor in the heart.

Authors:  Marta Gaburjakova; Naresh C Bal; Jana Gaburjakova; Muthu Periasamy
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

7.  Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies.

Authors:  Yijun Tang; Xixi Tian; Ruiwu Wang; Michael Fill; S R Wayne Chen
Journal:  Circ Res       Date:  2012-02-28       Impact factor: 17.367

Review 8.  Ryanodine receptor patents.

Authors:  Alexander Kushnir; Andrew R Marks
Journal:  Recent Pat Biotechnol       Date:  2012-12

9.  Ligand-dependent conformational changes in the clamp region of the cardiac ryanodine receptor.

Authors:  Xixi Tian; Yingjie Liu; Ying Liu; Ruiwu Wang; Terence Wagenknecht; Zheng Liu; S R Wayne Chen
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

10.  Subcellular Ca2+ signaling in the heart: the role of ryanodine receptor sensitivity.

Authors:  Benjamin L Prosser; Christopher W Ward; W J Lederer
Journal:  J Gen Physiol       Date:  2010-08       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.